EDGIO INC (EGIO)

US53261M2035 - Common Stock

1.11  -0.27 (-19.57%)

After market: 1.0496 -0.06 (-5.44%)

Fundamental Rating

2

EGIO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 83 industry peers in the IT Services industry. Both the profitability and financial health of EGIO have multiple concerns. EGIO is quite expensive at the moment. It does show a decent growth rate.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

EGIO had negative earnings in the past year.
In the past year EGIO has reported a negative cash flow from operations.
In the past 5 years EGIO reported 4 times negative net income.
Of the past 5 years EGIO 4 years had a positive operating cash flow.

1.2 Ratios

EGIO has a worse Return On Assets (-33.85%) than 86.75% of its industry peers.
EGIO has a Return On Equity of -99.89%. This is in the lower half of the industry: EGIO underperforms 74.70% of its industry peers.
Industry RankSector Rank
ROA -33.85%
ROE -99.89%
ROIC N/A
ROA(3y)-17.23%
ROA(5y)-10.88%
ROE(3y)-38.66%
ROE(5y)-23.93%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 29.13%, EGIO is doing worse than 66.27% of the companies in the same industry.
In the last couple of years the Gross Margin of EGIO has declined.
The Profit Margin and Operating Margin are not available for EGIO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.6%
GM growth 5Y-7.61%

More info and screens

1

2. Health

2.1 Basic Checks

EGIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EGIO has more shares outstanding
EGIO has more shares outstanding than it did 5 years ago.
EGIO has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -2.18, we must say that EGIO is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -2.18, EGIO is not doing good in the industry: 86.75% of the companies in the same industry are doing better.
EGIO has a Debt/Equity ratio of 0.89. This is a neutral value indicating EGIO is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.89, EGIO is doing worse than 63.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z -2.18
ROIC/WACCN/A
WACC3.38%

2.3 Liquidity

A Current Ratio of 0.85 indicates that EGIO may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.85, EGIO is doing worse than 79.52% of the companies in the same industry.
A Quick Ratio of 0.85 indicates that EGIO may have some problems paying its short term obligations.
EGIO's Quick ratio of 0.85 is on the low side compared to the rest of the industry. EGIO is outperformed by 79.52% of its industry peers.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.85

More info and screens

5

3. Growth

3.1 Past

The earnings per share for EGIO have decreased strongly by -33866.67% in the last year.
Looking at the last year, EGIO shows a very strong growth in Revenue. The Revenue has grown by 37.59%.
EGIO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.93% yearly.
EPS 1Y (TTM)-33866.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3400%
Revenue 1Y (TTM)37.59%
Revenue growth 3Y19.06%
Revenue growth 5Y12.93%
Sales Q2Q%-12.45%

3.2 Future

Based on estimates for the next years, EGIO will show a very strong growth in Earnings Per Share. The EPS will grow by 118.32% on average per year.
Based on estimates for the next years, EGIO will show a quite strong growth in Revenue. The Revenue will grow by 9.99% on average per year.
EPS Next Y-4320%
EPS Next 2Y-390.68%
EPS Next 3Y106.46%
EPS Next 5Y118.32%
Revenue Next Year8.61%
Revenue Next 2Y4.75%
Revenue Next 3Y8.35%
Revenue Next 5Y9.99%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EGIO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EGIO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

EGIO's earnings are expected to grow with 106.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-390.68%
EPS Next 3Y106.46%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EGIO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EDGIO INC

NASDAQ:EGIO (9/17/2024, 8:02:28 PM)

After market: 1.0496 -0.06 (-5.44%)

1.11

-0.27 (-19.57%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)04-25 2024-04-25/amc
Earnings (Next)10-17 2024-10-17/amc
Inst Owners0.02%
Inst Owner Change-99.76%
Ins Owners118.55%
Ins Owner Change-2.13%
Market Cap6.50M
Analysts45.71
Price Target30.6 (2656.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.92%
Min EPS beat(2)2.79%
Max EPS beat(2)19.05%
EPS beat(4)3
Avg EPS beat(4)-12.91%
Min EPS beat(4)-90.08%
Max EPS beat(4)19.05%
EPS beat(8)5
Avg EPS beat(8)31.31%
EPS beat(12)5
Avg EPS beat(12)-26.93%
EPS beat(16)8
Avg EPS beat(16)-1.13%
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)-1.2%
Revenue beat(4)0
Avg Revenue beat(4)-6.58%
Min Revenue beat(4)-23.22%
Max Revenue beat(4)-0.42%
Revenue beat(8)0
Avg Revenue beat(8)-8.58%
Revenue beat(12)0
Avg Revenue beat(12)-8.9%
Revenue beat(16)2
Avg Revenue beat(16)-6.58%
PT rev (1m)34.33%
PT rev (3m)34.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.9%
EPS NY rev (1m)0%
EPS NY rev (3m)1.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B 0.04
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-10.19
EYN/A
EPS(NY)-5.78
Fwd EYN/A
FCF(TTM)-8.69
FCFYN/A
OCF(TTM)-6.65
OCFYN/A
SpS64.83
BVpS26.21
TBVpS-15.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.85%
ROE -99.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.13%
FCFM N/A
ROA(3y)-17.23%
ROA(5y)-10.88%
ROE(3y)-38.66%
ROE(5y)-23.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.6%
GM growth 5Y-7.61%
F-Score2
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30.49%
Cap/Sales 3.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.85
Altman-Z -2.18
F-Score2
WACC3.38%
ROIC/WACCN/A
Cap/Depr(3y)94.14%
Cap/Depr(5y)108.41%
Cap/Sales(3y)11.25%
Cap/Sales(5y)11.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33866.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3400%
EPS Next Y-4320%
EPS Next 2Y-390.68%
EPS Next 3Y106.46%
EPS Next 5Y118.32%
Revenue 1Y (TTM)37.59%
Revenue growth 3Y19.06%
Revenue growth 5Y12.93%
Sales Q2Q%-12.45%
Revenue Next Year8.61%
Revenue Next 2Y4.75%
Revenue Next 3Y8.35%
Revenue Next 5Y9.99%
EBIT growth 1Y-75.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year14.19%
EBIT Next 3Y40.08%
EBIT Next 5Y32.04%
FCF growth 1Y-113.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-494.67%
OCF growth 3YN/A
OCF growth 5YN/A